Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus.
Hirano D, Kato H, Kodaira T, Yatabe Y, Ueda N, Murakami S, Higuchi Y, Taji H, Nakamura S, Yamamoto K, Kinoshita T. Hirano D, et al. Among authors: murakami s. Ann Hematol. 2015 Jan;94(1):173-5. doi: 10.1007/s00277-014-2128-7. Epub 2014 Jun 20. Ann Hematol. 2015. PMID: 24947796 No abstract available.
Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.
Totani H, Ri M, Kato C, Nakashima T, Suzuki N, Hagiwara S, Kanamori T, Murakami S, Masuda A, Kinoshita S, Yoshida T, Narita T, Ito A, Kusumoto S, Ishida T, Komatsu H, Iida S. Totani H, et al. Among authors: murakami s. Int J Hematol. 2016 Mar;103(3):316-21. doi: 10.1007/s12185-015-1925-7. Epub 2015 Dec 29. Int J Hematol. 2016. PMID: 26715148 Clinical Trial.
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line.
Sakurai M, Okamoto S, Matsumura I, Murakami S, Takizawa M, Waki M, Hirano D, Watanabe-Nakaseko R, Kobayashi N, Iino M, Mitsui H, Ishikawa Y, Takahashi N, Kawaguchi T, Suzuki R, Yamamoto K, Kizaki M, Ohnishi K, Naoe T, Akashi K; New TARGET investigators. Sakurai M, et al. Among authors: murakami s. Int J Hematol. 2020 Jun;111(6):812-825. doi: 10.1007/s12185-020-02843-8. Epub 2020 Mar 9. Int J Hematol. 2020. PMID: 32152876
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.
Kinoshita T, Hatake K, Yamamoto K, Higuchi Y, Murakami S, Terui Y, Yokoyama M, Maruyama D, Makita S, Hida Y, Saito T, Tobinai K. Kinoshita T, et al. Among authors: murakami s. Jpn J Clin Oncol. 2021 Jan 1;51(1):70-77. doi: 10.1093/jjco/hyaa169. Jpn J Clin Oncol. 2021. PMID: 33029633 Free PMC article. Clinical Trial.
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Murakami S, Ri M, Ito M, Nakamura N, Kasahara S, Kitagawa J, Inagaki Y, Kuroda J, Yoshimitsu M, Okamoto A, Fukuhara N, Taji H, Iida H, Nagai H, Hanamura I, Tsujimura H, Okura M, Kurata M, Kuwatsuka Y, Atsuta Y, Iida S. Murakami S, et al. Int J Hematol. 2022 Oct;116(4):563-569. doi: 10.1007/s12185-022-03379-9. Epub 2022 Jun 14. Int J Hematol. 2022. PMID: 35699890
Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.
Uchino K, Sakai K, Shinohara S, Matsuhisa A, Iida Y, Nakano Y, Matsumura S, Kanasugi J, Takasugi S, Nakamura A, Horio T, Murakami S, Mizuno S, Yamamoto H, Hanamura I, Matsumoto M, Takami A. Uchino K, et al. Among authors: murakami s. Int J Hematol. 2022 Aug;116(2):295-301. doi: 10.1007/s12185-022-03319-7. Epub 2022 Mar 10. Int J Hematol. 2022. PMID: 35274194 Review.
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.
Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A. Mizuno S, et al. Among authors: murakami s. FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec. FEBS Open Bio. 2018. PMID: 30524948 Free PMC article.
3,016 results